Biotech news

Reset all filters
Geography
Company
Refine search
Sequenom and Illumina prevail in UK confidentiality dispute
Americas
The England and Wales High Court has ruled in favour of Sequenom and Illumina, after the companies asked the court to rule that they were entitled to receive confidential information in legal proceedings against three competitors without additional restriction.   24 January 2019
EPO invalidates Pacific Biosciences patent in Oxford Nanopore dispute
Biotech
The European Patent Office has revoked a patent held by a US biotechnology company, Pacific Biosciences, after its UK-based rival Oxford Nanopore Technologies challenged the validity of the patent.   23 January 2019
South Korean global licensing spikes n 2018
Asia-Pacific
South Korean pharmaceutical companies entered into 11 out-licensing deals with overseas partners in 2018, according to the country’s Ministry of Health and Welfare.   22 January 2019
Americas
US-based medical technology company GE Healthcare has entered into a five-year partnership with Vanderbilt University Medical Center to develop cancer immunotherapies using artificial intelligence.   17 January 2019
Americas
The US Food and Drug Administration has announced new policies to advance the development of safe and effective cell and gene therapies.   16 January 2019
Americas
US law firm McGuire Woods is expanding its life sciences patent litigation team with the addition of three partners in its New York office.   15 January 2019
Pharma
Multinational pharmaceutical company Sanofi has entered into a licensing agreement with Paris-based biopharmaceutical company Biomunex.   15 January 2019
Pharma
The number of international investors in life sciences start-ups in the Catalonia region in Spain has multiplied by ten in the last five years, according to a new report.   10 January 2019
Americas
The US Supreme Court has refused to hear an appeal against a ruling that American pharmaceutical firm Merck & Co cannot collect $200 million in damages due to its misconduct during a trial.   10 January 2019
Biotech
US-based Locus Biosciences has announced it will license its CRISPR-Cas3 technology to Janssen, a subsidiary of American pharmaceutical company Johnson & Johnson, in a deal worth a potential $818 million.   9 January 2019